Cite
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
MLA
Moore-Palhares, Daniel, et al. “Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.” International Journal of Radiation Oncology, Biology, Physics, vol. 119, no. 4, July 2024, pp. 1110–21. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2024.01.213.
APA
Moore-Palhares, D., Zeng, K. L., Tseng, C.-L., Chen, H., Myrehaug, S., Soliman, H., Maralani, P., Larouche, J., Shakil, H., Jerzak, K., Ruschin, M., Zhang, B., Atenafu, E. G., Sahgal, A., & Detsky, J. (2024). Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure. International Journal of Radiation Oncology, Biology, Physics, 119(4), 1110–1121. https://doi.org/10.1016/j.ijrobp.2024.01.213
Chicago
Moore-Palhares, Daniel, K. Liang Zeng, Chia-Lin Tseng, Hanbo Chen, Sten Myrehaug, Hany Soliman, Pejman Maralani, et al. 2024. “Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.” International Journal of Radiation Oncology, Biology, Physics 119 (4): 1110–21. doi:10.1016/j.ijrobp.2024.01.213.